Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oncology Institute (TOI) Cash from Financing Activities (2020 - 2025)

Historic Cash from Financing Activities for Oncology Institute (TOI) over the last 6 years, with Q3 2025 value amounting to $10.6 million.

  • Oncology Institute's Cash from Financing Activities rose 446213.99% to $10.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.7 million, marking a year-over-year increase of 24991.19%. This contributed to the annual value of -$3.5 million for FY2024, which is 4899.96% up from last year.
  • According to the latest figures from Q3 2025, Oncology Institute's Cash from Financing Activities is $10.6 million, which was up 446213.99% from $2.0 million recorded in Q2 2025.
  • Oncology Institute's 5-year Cash from Financing Activities high stood at $136.1 million for Q4 2021, and its period low was -$10.7 million during Q2 2022.
  • Over the past 5 years, Oncology Institute's median Cash from Financing Activities value was -$847000.0 (recorded in 2022), while the average stood at $12.8 million.
  • Per our database at Business Quant, Oncology Institute's Cash from Financing Activities tumbled by 29060967.74% in 2021 and then skyrocketed by 131753750.0% in 2022.
  • Over the past 5 years, Oncology Institute's Cash from Financing Activities (Quarter) stood at $136.1 million in 2021, then crashed by 100.62% to -$847000.0 in 2022, then plummeted by 110.27% to -$1.8 million in 2023, then soared by 90.79% to -$164000.0 in 2024, then soared by 6563.41% to $10.6 million in 2025.
  • Its last three reported values are $10.6 million in Q3 2025, $2.0 million for Q2 2025, and -$4.7 million during Q1 2025.